Home » Newsletters » BioWorld

BioWorld

Oct. 22, 1996

View Archived Issues

GENENTECH POSTS THIRD QUARTER PROFIT INCREASE OF 27 PERCENT

U.S. PATENT DISCLOSURES

VIRAL THERAPEUTICS WINS PATENT, SBIR GRANT FOR NEW HIV COFACTOR

PARADIGM BIOSCIENCES UNVEILS NOVEL GENITAL HERPES VACCINE

LIPOSOME COMPANY GETS EXPANDED LABEL FOR ABELCET

INTERNATIONAL BIOTECHNOLOGY TRUST VALUE DECLINES, SHARE PRICES RISE 22

LILLY TO PAY NEUROCRINE $74M FOR OBESITY, ALZHEIMER'S DRUGS

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.